PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsvon willebrand diseases
MeSH D014842 - von willebrand diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001791:Blood platelet disorders
0 Companies
0 Drugs
Success rate
D025861:Inherited blood coagulation disorders
$
Success rate
D020147:Coagulation protein disorders
0 Companies
0 Drugs
Success rate
D006474:Hemorrhagic disorders
$
Success rate
D014842: 
Von willebrand diseases
$
Success rate
D056725:Type 1 von willebrand disease
0 Companies
0 Drugs
Success rate
D056728:Type 2 von willebrand disease
0 Companies
0 Drugs
Success rate
D056729:Type 3 von willebrand disease
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novast LaboratoriesDesmopressin Desmopressin  2019-06-06   
Glenmark PharmaceuticalsDesmopressin Desmopressin  2015-05-28   
NATCO PharmaDesmopressin Desmopressin  2014-06-27   
Bausch Health CompaniesDesmopressin Desmopressin  1999-01-25   
Dr Reddys LaboratoriesDesmopressin Desmopressin  2022-08-19   
Zydus TherapeuticsDesmopressin Desmopressin  2017-10-03   
Sun Pharmaceutical IndustriesDesmopressin Desmopressin  2012-04-12   
ApotexDesmopressin Desmopressin  2005-01-27   
HospiraDesmopressin Desmopressin  2000-08-28   
Impax LaboratoriesDesmopressin Desmopressin  2006-01-25   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%
5/5
Phase 2
100%
5/5
Phase 3
93%
13/14
Approved: 6Overall Success rate: 93%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novo Nordisk
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use